1291622

SPI Pharma, Inc. — FEI 1833292

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 26, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Grand Haven, MI (United States)